DEBORAH HERTERICH: Open Payments
NPI 1437158383 · BEDFORD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$205 in 7 payments from 6 companies in 2025. Trend: 2023 $863 · 2024 $895 · 2025 $205
Food & beverage: $205
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $54 |
| TerSera Therapeutics LLC | 2 | $48 |
| Grifols USA, LLC | 1 | $32 |
| Janssen Biotech, Inc. | 1 | $29 |
| Genentech USA, Inc. | 1 | $25 |
| Amicus Therapeutics, Inc. | 1 | $17 |
Products named: VPRIV, Quzyttir, Gamunex-C, TREMFYA, Ocrevus Zunovo, POMBILITI.
Industry payments across TX — which companies pay providers there.
